$ORLY
O REILLY AUTOMOTIVE INC

2017 Q4 Form 10-Q Financial Statement

#000089817317000178 Filed on November 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q3
Revenue $2.191B $2.340B $2.221B
YoY Change 4.36% 5.35% 6.77%
Cost Of Revenue $1.032B $1.110B $1.051B
YoY Change 4.72% 5.58% 6.05%
Gross Profit $1.159B $1.230B $1.170B
YoY Change 4.03% 5.15% 7.42%
Gross Profit Margin 52.91% 52.58% 52.68%
Selling, General & Admin $756.3M $768.3M $722.2M
YoY Change 7.05% 6.39% 7.15%
% of Gross Profit 65.24% 62.45% 61.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $60.30M $58.50M $55.00M
YoY Change 6.73% 6.36% 5.57%
% of Gross Profit 5.2% 4.75% 4.7%
Operating Expenses $756.4M $768.3M $722.2M
YoY Change 7.06% 6.39% 7.15%
Operating Profit $402.8M $462.0M $447.8M
YoY Change -1.2% 3.16% 7.84%
Interest Expense -$26.20M -$23.70M -$17.50M
YoY Change 48.02% 35.43% 27.74%
% of Operating Profit -6.5% -5.13% -3.91%
Other Income/Expense, Net $100.0K -$22.43M -$15.92M
YoY Change -88.89% 40.95% 10.59%
Pretax Income $376.7M $439.5M $431.9M
YoY Change -3.63% 1.77% 7.74%
Income Tax $127.4M $155.8M $153.4M
% Of Pretax Income 33.82% 35.45% 35.52%
Net Earnings $302.3M $283.7M $278.5M
YoY Change 22.88% 1.88% 4.59%
Net Earnings / Revenue 13.8% 12.13% 12.54%
Basic Earnings Per Share $3.56 $3.26 $2.93
Diluted Earnings Per Share $3.52 $3.22 $2.90
COMMON SHARES
Basic Shares Outstanding 85.03M shares 86.95M shares 94.89M shares
Diluted Shares Outstanding 88.03M shares 96.12M shares

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.00M $37.00M $560.0M
YoY Change -68.71% -93.39% 102.17%
Cash & Equivalents $46.35M $37.29M $560.3M
Short-Term Investments
Other Short-Term Assets $49.04M $34.48M $32.03M
YoY Change -7.52% 7.65% -3.19%
Inventory $3.010B $2.988B $2.790B
Prepaid Expenses
Receivables $216.3M $219.6M $190.9M
Other Receivables $76.00M $79.00M $97.00M
Total Short-Term Assets $3.398B $3.358B $3.670B
YoY Change 4.29% -8.48% 16.22%
LONG-TERM ASSETS
Property, Plant & Equipment $3.344B $3.293B $3.059B
YoY Change 7.06% 7.65% 9.04%
Goodwill $789.1M $787.2M $757.3M
YoY Change 0.47% 3.96% 0.02%
Intangibles $9.392M
YoY Change -17.1%
Long-Term Investments
YoY Change
Other Assets $41.35M $40.96M $36.64M
YoY Change 10.61% 11.78% -11.05%
Total Long-Term Assets $4.174B $4.121B $3.853B
YoY Change 5.78% 6.96% 6.49%
TOTAL ASSETS
Total Short-Term Assets $3.398B $3.358B $3.670B
Total Long-Term Assets $4.174B $4.121B $3.853B
Total Assets $7.572B $7.479B $7.522B
YoY Change 5.1% -0.57% 11.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.190B $3.154B $2.999B
YoY Change 8.63% 5.17% 14.2%
Accrued Expenses $146.0M $147.0M $140.0M
YoY Change 0.0% 5.0% -6.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.647B $3.629B $3.465B
YoY Change 7.25% 4.71% 11.65%
LONG-TERM LIABILITIES
Long-Term Debt $2.978B $2.901B $1.887B
YoY Change 57.84% 53.77% 35.04%
Other Long-Term Liabilities $207.7M $204.0M $185.4M
YoY Change 4.25% 10.0% -7.32%
Total Long-Term Liabilities $3.186B $3.105B $2.072B
YoY Change 52.72% 49.85% 935.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.647B $3.629B $3.465B
Total Long-Term Liabilities $3.186B $3.105B $2.072B
Total Liabilities $6.833B $6.733B $5.537B
YoY Change 24.54% 21.6% 67.6%
SHAREHOLDERS EQUITY
Retained Earnings -$612.8M -$654.5M $560.3M
YoY Change -311.69% -216.81% -23.53%
Common Stock $1.266B $1.269B $1.340B
YoY Change -5.36% -5.36% 5.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $653.0M $614.2M $1.901B
YoY Change
Total Liabilities & Shareholders Equity $7.572B $7.479B $7.522B
YoY Change 5.1% -0.57% 11.03%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $302.3M $283.7M $278.5M
YoY Change 22.88% 1.88% 4.59%
Depreciation, Depletion And Amortization $60.30M $58.50M $55.00M
YoY Change 6.73% 6.36% 5.57%
Cash From Operating Activities $316.3M $376.9M $385.6M
YoY Change 6.71% -2.26% 5.88%
INVESTING ACTIVITIES
Capital Expenditures -$118.1M -$120.3M -$135.8M
YoY Change -1.67% -11.41% 23.45%
Acquisitions
YoY Change
Other Investing Activities $1.900M $1.000M $500.0K
YoY Change -103.37% 100.0% -68.75%
Cash From Investing Activities -$116.3M -$119.2M -$135.3M
YoY Change -34.07% -11.9% 24.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -190.9M -246.9M -88.10M
YoY Change -64.24% 180.25% -63.15%
NET CHANGE
Cash From Operating Activities 316.3M 376.9M 385.6M
Cash From Investing Activities -116.3M -119.2M -135.3M
Cash From Financing Activities -190.9M -246.9M -88.10M
Net Change In Cash 9.100M 10.80M 162.2M
YoY Change -102.2% -93.34% 865.48%
FREE CASH FLOW
Cash From Operating Activities $316.3M $376.9M $385.6M
Capital Expenditures -$118.1M -$120.3M -$135.8M
Free Cash Flow $434.4M $497.2M $521.4M
YoY Change 4.3% -4.64% 9.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
264.88
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2016Q4 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
74454000 USD
CY2017Q3 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
65574000 USD
CY2016Q4 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0 USD
CY2017Q3 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0 USD
CY2016Q3 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
267.66
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000898173
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85027697 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
O REILLY AUTOMOTIVE INC
CY2017Q3 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
246.65
orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
258.75
CY2017Q2 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
1000000000 USD
CY2017Q3 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
1000000000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2936656000 USD
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3154250000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
197274000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
219631000 USD
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6175000 USD
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
71717000 USD
CY2017Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
80953000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1708911000 USD
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1822123000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1336707000 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1267810000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1811000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2078000 USD
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
271000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
319000 shares
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
784000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
620000 shares
CY2016Q4 us-gaap Assets
Assets
7204189000 USD
CY2017Q3 us-gaap Assets
Assets
7479328000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
3257975000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
3358481000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116301000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
560320000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146598000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37287000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
444019000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-109311000 USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92851815 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85338294 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92851815 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85338294 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
929000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
853000 USD
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1050929000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3099010000 USD
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1109536000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3225415000 USD
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
Each of the senior notes is subject to certain customary covenants, with which the Company complied as of September 30, 2017.
us-gaap Debt Instrument Description
DebtInstrumentDescription
The Company has issued a cumulative $2.7 billion aggregate principal amount of unsecured senior notes, which are due between 2021 and 2027, with UMB as trustee. Interest on the senior notes, ranging from 3.550% to 4.875%, is payable semi-annually and is computed on the basis of a 360-day year.
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4439000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
41848000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
90166000 USD
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
131847000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
161447000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
173500000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.25
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.28
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.14
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.15
CY2016Q4 us-gaap Goodwill
Goodwill
785399000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
787210000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
1170026000 USD
us-gaap Gross Profit
GrossProfit
3394784000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
1230294000 USD
us-gaap Gross Profit
GrossProfit
3561503000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
431893000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1246261000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
439530000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1261080000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
153400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
454600000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
155796000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
429591000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
416901000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
359838000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
390849000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
217486000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35312000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28761000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
39636000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
32124000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
158877000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
208338000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-60000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2984000 USD
CY2016Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
900000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
1400000 USD
CY2017Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
1000000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
2600000 USD
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1229000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1315000 shares
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1078000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1228000 shares
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
18706000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
52228000 USD
CY2017Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
24324000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
64555000 USD
us-gaap Interest Paid Net
InterestPaidNet
59547000 USD
us-gaap Interest Paid Net
InterestPaidNet
72252000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
2778976000 USD
CY2017Q3 us-gaap Inventory Net
InventoryNet
2987592000 USD
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
20462000 USD
CY2017Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
24528000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7204189000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7479328000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3400649000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3628500000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1887019000 USD
CY2017Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2900816000 USD
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
18600000 USD
us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
12500000 USD
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Meridian Creative Alliance
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-417542000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-848808000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-352698000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-347922000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1214259000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1087419000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
278493000 USD
us-gaap Net Income Loss
NetIncomeLoss
791661000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
283734000 USD
us-gaap Net Income Loss
NetIncomeLoss
831489000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15916000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-45235000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22433000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61485000 USD
CY2016Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
82105000 USD
CY2017Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
79491000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
447809000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1291496000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
461963000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1322565000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
53022000 USD
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
34480000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37384000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40956000 USD
CY2016Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1227000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
3172000 USD
CY2017Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
592000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1768000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
249901000 USD
CY2017Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
249325000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
199219000 USD
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
203986000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4174000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8174000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1563000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3821000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1299000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1302000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2072000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
959789000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1893148000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4125000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7490000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
356234000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
347756000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1047000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
499160000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
748800000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
2487000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-207000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-156000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2489000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1906000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
47419000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
34186000 USD
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
36623000 USD
CY2017Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
41900000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
60173000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
65450000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4832342000 USD
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5114804000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3123431000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3292681000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
2218000000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
289500000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-654484000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2220955000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
6493794000 USD
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2339830000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
6786918000 USD
CY2016Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
67921000 USD
CY2017Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
72223000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
722217000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2103288000 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
768331000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2238938000 USD
CY2016Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1887019000 USD
CY2017Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
2631816000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14371000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14835000 USD
CY2017Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
9800000000 USD
CY2017Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2017Q3 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
994800000 USD
CY2016Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
367000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3673000 shares
CY2017Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2743000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
8047000 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1627136000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
614179000 USD
CY2016Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
281.04
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
261.32
CY2017Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
200.70
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
235.26
CY2016Q3 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
102941000 USD
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
959743000 USD
CY2017Q3 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
550530000 USD
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
1893068000 USD
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96120000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97309000 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88025000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90869000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94891000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95994000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86947000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89641000 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 1 - BASIS OF PRESENTATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements of O&#8217;Reilly Automotive, Inc. and its subsidiaries (the &#8220;Company&#8221; or &#8220;O&#8217;Reilly&#8221;) have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results that may be expected for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to current period presentation. These reclassifications had no effect on reported totals for assets, liabilities, shareholders&#8217; equity, cash flows or net income. See Note 9 &#8220;Recent Accounting Pronouncements&#8221; to the condensed consolidated financial statements in this report for more information.</font></div></div>

Files In Submission

Name View Source Status
0000898173-17-000178-index-headers.html Edgar Link pending
0000898173-17-000178-index.html Edgar Link pending
0000898173-17-000178.txt Edgar Link pending
0000898173-17-000178-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orly-20170930.xml Edgar Link completed
orly-20170930.xsd Edgar Link pending
orly-20170930x10q.htm Edgar Link pending
orly-20170930x10qexhibit311.htm Edgar Link pending
orly-20170930x10qexhibit312.htm Edgar Link pending
orly-20170930x10qexhibit321.htm Edgar Link pending
orly-20170930x10qexhibit322.htm Edgar Link pending
orly-20170930_cal.xml Edgar Link unprocessable
orly-20170930_def.xml Edgar Link unprocessable
orly-20170930_lab.xml Edgar Link unprocessable
orly-20170930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending